ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.

Timothy S Pardee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.